Skip to main content

Cleofé Romagosa Pérez-Portabell

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Cleofé Romagosa Pérez-Portabell

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Testing the Malignant Peripheral Nerve Sheath Tumor vulnerability to precision therapies directed to recurrent genomic alterations

IP: Soledad Gallego Melcón
Collaborators: Cleofé Romagosa Pérez-Portabell, Claudia Maria Valverde Morales
Funding agency: Fundació La Marató de TV3
Funding: 99647.5
Reference: 201939-32
Duration: 08/06/2020 - 18/11/2021

ESTUDIO SOBRE EL IMPACTO DEL DIAGNÓSTICO ANATOMOPATOLÓGICO CENTRALIAZADO DE SARCOMAS DE PARTES BLANDAS EN EL ESTADO ESPAÑOL

IP: Cleofé Romagosa Pérez-Portabell
Collaborators: -
Funding agency: Fundación Mari Paz Jimenez Casado
Funding: 75000
Reference: FMPJC/SARCOMA/ROMAGOSA
Duration: 01/01/2019 - 31/12/2021

Study of the Main Molecular Pathways Activating Brachiury in Chordomas (PDGFR, EGFR, FGFR and Wnt)

IP: Cleofé Romagosa Pérez-Portabell
Collaborators: -
Funding agency: Grupo Español Investigación en Sarcomas GEIS
Funding: 8000
Reference: GEIS/BRACHURY/2016/CLEOFÉ
Duration: 06/06/2016 - 05/06/2019

Anatomia Patològica (GRC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Inés de Torres Ramirez, Angel García Jiménez, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Stefania Landolfi , Trond Aasen
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1131
Duration: 01/01/2014 - 31/12/2016

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Roger Rica Peiro

Roger Rica Peiro

Technological Infrastructure Unit
Digital Transformation Directorate
Read more
Africa Hontalba Rifa

Africa Hontalba Rifa

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Jaime Llata Ortega

Jaime Llata Ortega

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Hanaa Boudoukhan Benriyyan

Hanaa Boudoukhan Benriyyan

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.